What Has Driven the Growth of the Non-Steroidal Anti-inflammatory Drugs Market in Recent Years?
The non-steroidal anti-inflammatory drugs market has seen considerable growth due to a variety of factors.
• The market size for non-steroidal anti-inflammatory drugs has seen significant growth recently. The forecast projects an increase from $20.68 billion in 2024 to $22.1 billion in 2025, manifesting a compound annual growth rate (CAGR) of 6.8%. Several factors have contributed to this growth throughout the historic period, including chronic inflammatory conditions, management of pain after surgery, sports-related injuries, over-the-counter accessibility, an aging demographic, and increased consumer awareness.
What Are the Future Growth Projections for the Non-Steroidal Anti-inflammatory Drugs Market?
The Non-Steroidal Anti-inflammatory Drugs market is expected to maintain its strong growth trajectory in upcoming years.
• Rapid expansion is anticipated in the non-steroidal anti-inflammatory drugs market in the upcoming years. Its value is projected to reach $28.79 billion by 2029 with a compound annual growth rate (CAGR) of 6.8%.
The projected growth during this period can be attributed to factors such as the emergence of new pain management therapies, changes in regulations, the application of telehealth, global wellness movements, competition from biosimilars, patient choices, and the application of precision medicine. The forecast period is expected to see more trends such as dominance of over-the-counter (OTC) market, increased inclination towards cox-2 inhibitors, generics and market competitors, and the adoption of digital health technologies.
What Are The Core Factors Supporting Growth In The Non-Steroidal Anti-inflammatory Drugs Market?
The non-steroidal anti-inflammatory drugs market is projected to expand due to the rising instances of chronic pain. Chronic pain, defined as discomfort persisting longer than six months, frequently results from arthritis, as reported by the CDC (Centers for Disease Control and Prevention) in April 2022. Non-steroidal anti-inflammatory drugs serve to alleviate injuries and manage chronic pain. The CDC's report reveals arthritis as a common source of lingering pain, affecting millions in the United States, with roughly a quarter of 15 million adults bearing severe joint pain associated with the condition. Consequently, the escalating occurrences of chronic pain significantly contribute to the growth momentum of the non-steroidal anti-inflammatory drugs market.
What Are The Major Segments Within The Global Non-Steroidal Anti-inflammatory Drugs Market?
The non-steroidal anti-inflammatory drugs market covered in this report is segmented –
1) By Route Of Administration: Oral, Topical, Other Route Of Administration
2) By Disease Indication: Arthritis, Migraine, Ophthalmic Diseases, Other Disease Indications
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Oral: Tablets, Capsules, Liquids Or Solutions
2) By Topical: Gels, Creams, Patches
3) By Other Route Of Administration: Injectable (Intravenous And Intramuscular), Suppositories
Pre-Book The Non-Steroidal Anti-inflammatory Drugs Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Non-Steroidal Anti-inflammatory Drugs Market?
In the non-steroidal anti-inflammatory drugs market, the primary trend is the innovation of products. The leading entities in this market sphere are focusing on inventing new technological resolutions. Illustratively, Endo International plc, a pharmaceutical industry leader based in Ireland, introduced ibuprofen-famotidine 800 mg/26.6 mg tablets in March 2024. These tablets bind the pain-relieving and anti-inflammatory features of ibuprofen with famotidine's protective effects on the stomach. The purpose of this formulation is to soothe pain while simultaneously decreasing the likelihood of experiencing gastrointestinal side effects that can happen during the prolonged use of non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen.
Who Are the Key Players In The Non-Steroidal Anti-inflammatory Drugs Market?
Major companies operating in the non-steroidal anti-inflammatory drugs market include:
• Pfizer Inc.
• Bayer AG
• Johnson & Johnson
• Sun Pharmaceutical Industries Ltd.
• Assertio Therapeutics Inc.
• Iroko Pharmaceuticals Inc.
• Reckitt Benckiser Group PLC
• Perrigo Company PLC
• Hikma Pharmaceuticals Public Limited Company
• Glenmark Pharmaceuticals Limited
• Septodont
• Aspen Pharmacare Holdings Limited
• Sagent Pharmaceuticals Inc.
• Advanced Pharma Inc.
• Akorn Operating Company LLC
• Alembic Pharmaceuticals Limited
• Torrent Pharmaceuticals Limited
• Lupin Limited
• Cipla Limited
• Zydus Cadila Healthcare Limited
• Aurobindo Pharma Limited
• Sanofi S.A.
• GlaxoSmithKline PLC
• Horizon Therapeutics PLC
• Zyla Life sciences
• Novartis AG
• Roche Holding AG
• AbbVie Inc.
• Bristol-Myers Squibb Company
What Is The Most Dominant Region In The Non-Steroidal Anti-inflammatory Drugs Market?
North America was the largest region in the non-steroidal anti-inflammatory drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the non-steroidal anti-inflammatory drugs market during the forecast period. The regions covered in the non-steroidal anti-inflammatory drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
